文献速递白血病淋巴瘤浆细胞疾病

核工业工人低水平电离辐射暴露后白血病、淋巴瘤和多发性骨髓瘤死亡率(INWORKS):国际队列研究的更新结果

Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study.
PubMed 文献 · Lancet Haematol · 2024-08-30

采用泊松回归估计红骨髓剂量与血液系统恶性肿瘤死亡率的关联,发现除慢性淋巴细胞白血病外白血病、慢性髓系白血病、骨髓增生异常综合征及多发性骨髓瘤死亡率与辐射剂量呈正关联,非霍奇金和霍奇金淋巴瘤关联证据极少。

要点

  • 红骨髓累积剂量(滞后2年)与除慢性淋巴细胞白血病外白血病死亡率呈线性正关联,每Gy的ERR为2.68(90%CI 1.13至4.55,n=771)。
  • 慢性髓系白血病(ERR每Gy 9.57,90%CI 4.00至17.91,n=122)和骨髓增生异常综合征(ERR每Gy 3.19,90%CI 0.35至7.33,n=163)也呈正关联。
  • 多发性骨髓瘤与辐射剂量呈正关联(ERR每Gy 1.62,90%CI 0.06至3.64,n=527),非霍奇金和霍奇金淋巴瘤关联证据极少。

核心结论

  • 本研究报道长期低剂量电离辐射暴露与部分血液系统恶性肿瘤死亡率之间存在正关联。
  • 鉴于本研究工人累积剂量相对较低(平均累积红骨髓剂量16 mGy),该人群中辐射归因的白血病死亡绝对风险较低(35年期间每1万名工人中约1例超额死亡)。
  • 这些结果可为辐射防护标准提供信息,并将为辐射防护系统的讨论提供输入。

研究设计与样本

  • 国际核工业工人研究(INWORKS)更新,纳入法国(60697名)、英国(147872名)和美国(101363名)核设施中受辐射监测且就业至少1年的309932名工人(269487名[87%]男性,40445名[13%]女性)。
  • 采用泊松回归方法量化红骨髓辐射剂量与血液系统恶性肿瘤死亡率的关联,以每Gy的超额相对率(ERR)表示。

主要发现

  • 红骨髓累积剂量(滞后2年)与除慢性淋巴细胞白血病(CLL)外白血病死亡率呈线性正关联,ERR每Gy 2.68(90%CI 1.13至4.55,n=771),未受中子暴露、内污染监测状态或雇佣时期修饰。
  • 慢性髓系白血病死亡率与辐射剂量呈正关联,ERR每Gy 9.57(90%CI 4.00至17.91,n=122)。
  • 骨髓增生异常综合征单独(ERR每Gy 3.19,90%CI 0.35至7.33,n=163)或与急性髓系白血病合并(ERR每Gy 1.55,90%CI 0.05至3.42,n=598)均与辐射剂量呈正关联。
  • 急性淋巴细胞白血病(ERR每Gy 4.25,90%CI -4.19至19.32,n=49)和CLL(ERR每Gy 0.20,90%CI -1.81至2.21,n=242)未见显著关联。
  • 多发性骨髓瘤与辐射剂量呈正关联(ERR每Gy 1.62,90%CI 0.06至3.64,n=527),非霍奇金淋巴瘤(ERR每Gy 0.27,90%CI -0.61至1.39,n=1146)和霍奇金淋巴瘤(ERR每Gy 0.60,90%CI -3.64至4.83,n=122)关联证据极少。

关键数值与推荐

  • 除CLL外白血病:ERR每Gy 2.68(90%CI 1.13至4.55,n=771)。
  • 慢性髓系白血病:ERR每Gy 9.57(90%CI 4.00至17.91,n=122)。
  • 骨髓增生异常综合征:ERR每Gy 3.19(90%CI 0.35至7.33,n=163);与急性髓系白血病合并:ERR每Gy 1.55(90%CI 0.05至3.42,n=598)。
  • 多发性骨髓瘤:ERR每Gy 1.62(90%CI 0.06至3.64,n=527)。
  • 非霍奇金淋巴瘤:ERR每Gy 0.27(90%CI -0.61至1.39,n=1146);霍奇金淋巴瘤:ERR每Gy 0.60(90%CI -3.64至4.83,n=122)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A major update to the International Nuclear Workers Study (INWORKS) was undertaken to strengthen understanding of associations between low-dose exposure to penetrating forms of ionising radiation and mortality. Here, we report on associations between radiation dose and mortality due to haematological malignancies. METHODS: We assembled a cohort of 309 932 radiation-monitored workers (269 487 [87%] males and 40 445 [13%] females) employed for at least 1 year by a nuclear facility in France (60 697 workers), the UK (147 872 workers), and the USA (101 363 workers). Workers were individually monitored for external radiation exposure and followed-up from Jan 1, 1944, to Dec 31, 2016, accruing 10·72 million person-years of follow-up. Radiation-mortality associations were quantified in terms of the excess relative rate (ERR) per Gy of radiation dose to red bone marrow for leukaemia excluding chronic lymphocytic leukaemia (CLL), as well as subtypes of leukaemia, myelodysplastic syndromes, non-Hodgkin and Hodgkin lymphomas, and multiple myeloma. Estimates of association were obtained using Poisson regression methods. FINDINGS: The association between cumulative dose to red bone marrow, lagged 2 years, and leukaemia (excluding CLL) mortality was well described by a linear model (ERR per Gy 2·68, 90% CI 1·13 to 4·55, n=771) and was not modified by neutron exposure, internal contamination monitoring status, or period of hire. Positive associations were also observed for chronic myeloid leukaemia (9·57, 4·00 to 17·91, n=122) and myelodysplastic syndromes alone (3·19, 0·35 to 7·33, n=163) or combined with acute myeloid leukaemia (1·55, 0·05 to 3·42, n=598). No significant association was observed for acute lymphoblastic leukaemia (4·25, -4·19 to 19·32, n=49) or CLL (0·20, -1·81 to 2·21, n=242). A positive association was observed between radiation dose and multiple myeloma (1·62, 0·06 to 3·64, n=527) whereas minimal evidence of association was observed between radiation dose and non-Hodgkin lymphoma (0·27, -0·61 to 1·39, n=1146) or Hodgkin lymphoma (0·60, -3·64 to 4·83, n=122) mortality. INTERPRETATION: This study reports a positive association between protracted low dose exposure to ionising radiation and mortality due to some haematological malignancies. Given the relatively low doses typically accrued by workers in this study (16 mGy average cumulative red bone marrow dose) the radiation attributable absolute risk of leukaemia mortality in this population is low (one excess death in 10 000 workers over a 35-year period). These results can inform radiation protection standards and will provide input for discussions on the radiation protection system. FUNDING: National Cancer Institute, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Institut de Radioprotection et de Sûreté Nucléaire, Orano, Electricité de France, UK Health Security Agency. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Leuraud K, Laurier D, Gillies M, et al. Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study. Lancet Haematol. 2024. PMID: 39222647. doi:10.1016/S2352-3026(24)00240-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。